Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.1B | 3.8B | 4.1B | 4.0B |
Cost of revenue | 2.7B | 2.5B | 2.7B | 2.6B |
Gross profit | 1.5B | 1.4B | 1.4B | 1.4B |
Operating expense | ||||
Research & development | 203M | 188M | 195M | 189M |
Selling general and admin | 454M | 427M | 433M | 431M |
Other operating expenses | — | — | — | — |
Operating income | 802M | 745M | 755M | 766M |
Non operating interest income | ||||
Income | 22M | 23M | 26M | 20M |
Expense | 14M | 6M | 15M | 18M |
Other income expense | -55M | -56M | -109M | -14M |
Pretax income | 755M | 706M | 657M | 754M |
Tax provision | 742M | 178M | 381M | 181M |
Net income | 13M | 528M | 276M | 573M |
Basic EPS | 0.0 | 1.8 | 0.9 | 1.9 |
Diluted EPS | 0.0 | 1.8 | 0.9 | 1.9 |
Basic average shares | 298M | 299M | 303M | 306M |
Diluted average shares | 300M | 301M | 305M | 308M |
EBITDA | 1.0B | 953M | 996M | 991M |
Net income from continuing op. | 13M | 528M | 276M | 573M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |